Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralizing activity after passage through the human stomach and small intestine

Gut

Volumn 44, Issue 2, 1999, Pages 212-217

  Warny, M ^a   Fatimi, A ^a   Bostwick, E F ^b   Laine, D C ^b   Lebel, F ^b   LaMont, J T ^a   Pothoulakis, C ^a   Kelly, C P ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GalaGen Inc   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Antibiotic; Clostridium difficile; Diarrhoea; IgG; Immunotherapy; Pseudomembranous colitis; Toxin

Indexed keywords

BOVINE IMMUNOGLOBULIN; CLOSTRIDIUM DIFFICILE TOXIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL INFECTION; CATTLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; COLITIS; COLOSTRUM; DIARRHEA; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL;

EID: 0033027528     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.2.212     Document Type: Article

References (31)

1. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997;92:739-50.
2. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
3. Pothoulakis C. Pathogenesis of Clostridium difficile-associated diarrhoea. Eur J Gastroenterol Hepatol 1996;8:1041-7.
4. Riegler M, Sedivy R, Pothoulakis C, et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995;95:2004-11.
5. Just I, Wilm M, Selzer J, et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995;270:13932-6.
6. Just I, Selzer J, Wilm M, et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995;375:500-3.
7. Borriello SP. The influence of the normal flora on Clostridium difficile colonisation of the gut. Ann Med 1990;22:61-7.
8. Linevsky JK, Kelly CP. Clostridium difficile colitis. In: LaMont JT, ed. Gastrointestinal infections: diagnosis and management. New York: Marcel Dekker, 1997:293-325.
9. Lyerly DM, Bostwick EF, Binion SB, et al. Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991;59:2215-18.
10. Kelly CP, Pothoulakis C, Vavva F, et al. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicitv of C difficile toxins. Antimicrob Agents Chemother 1996;40:373-9.
11. Kelly CP, Chetham S, Keates S, et al. Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrob Agents Chemother 1997;41:236-41.
12. Nord J, Ma P, DiJohn D, et al. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 1990;4:581-4.
13. Davidson GP, Whyte PB, Daniels E, et al. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 1989;ii:709-12.
14. Tacket CO, Losonsky G, Link H, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 1988;318:1240-3.
15. Tacket CO, Binion SB, Bostwick E, et al. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg 1992;47:276-83.
16. Mietens C, Keinhorst H, Hilpert H, et al. Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins. Eur J Pediatr 1979;132:239-52.
17. Brunser O, Espinoza J, Figueroa G, et al. Field trial of an infant formula containing anti-rotavirus and anti-Escherichia coli milk antibodies from hyperimmunized cows. J Pediatr Gastroenterol Nutr 1992;15:63-72.
18. Brussow H, Hilpert H, Walther I, et al. Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. J Clin Microbiol 1987;25:982-6.
19. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J Nutr 1995;125:1238-44.
20. Libby JM, Jortner BS, Wilkins TD. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun 1982;36:822-9.
21. Fernie DS, Thomson RO, Batty I, et al. Active and passive immunization to protect against antibiotic associated caecitis in hamsters. Dev Biol Stand 1983;53:325-32.
22. Kim PH, Iaconis JP, Rolfe RD. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect Immun 1987;55:2984-92.
23. Aronsson B, Granstrom M, Mollby R, et al. Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection 1985;13:97-101.
24. Johnson S, Gerding DN, Janoff EN. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile. J Infect Dis 1992;166:1287-94.
25. Kelly CP. Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 1996;8:1048-53.
26. Leung DY, Kelly CP, Boguniewicz M, et al. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991;118:633-7.
27. Mulligan ME, Miller SD, McFarland LV, et al. Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile. Clin Infect Dis 1993;16(suppl 4):S239-44.
28. Warny M, Vaerman JP, Avesani V, et al. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994;62:384-9.
29. Allo M, Silva J, Jr, Fekety R, et al. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology 1979;76:351-5.
30. Salcedo J, Keates S, Pothoulakis C, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997;41:366-70.
31. Tjellstrom B, Stenhammar I., Eriksson S, et al. Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet 1993;341:701-2.